Former director (through FY2025) · Starling Oncology, Inc. (STLN)

Richard Barasch director compensation at Starling (FY2025): $0

Fiscal year 2025 director compensation for Richard Barasch at Starling Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Richard Barasch’s full pay file as a PDF — free

More than this page: up to 10 years of Richard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Richard Barasch and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Starling Oncology Director Compensation Table · all 3 fiscal years held
In US dollars, as Starling Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$0$0$0
FY2024$0$12,400—$0$12,400
FY2023$0$162,400—$0$162,400

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Starling Oncology, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197350, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Starling Oncology, Inc. filed document, accession 0001193125-26-197350. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Starling Oncology Board Governance Report

$0 Richard Barasch, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Starling Oncology pays directors a $75,000 cash retainer and $125,000 in RSUs.

The rest of the Starling Oncology board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anne McGeorgeChair of the Board$424,998
Brad HivelyIndependent Director$315,000
Daniel VirnichDirector—
Karen JohnsonIndependent Director$350,001
Kimberly TzoumakasIndependent Director—
Mark PacalaIndependent Director$340,000
Mark StolperIndependent Director—
Mohit KaushalIndependent Director$369,999

The full Starling Oncology compensation record

free company brief

This page is one director within Starling Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Order STLN

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report